Breaking News Instant updates and real-time market news.

ABMD

Abiomed

$405.08

-8.51 (-2.06%)

19:15
11/11/18
11/11
19:15
11/11/18
19:15

Abiomed positive updates should push shares higher, says Piper Jaffray

Piper Jaffray analyst Matt O'Brien notes that Abiomed announced positive results of its Door to Unload STEMI safety and feasibility study, and announced it would be conducting a pivotal trial to pursue this indication, which would be the first of its kind in STEMI and would meaningfully alter the paradigm of heart health standard of care if positive. The analyst believes that these positive updates will likely push shares higher tomorrow. O'Brien continues to view Abiomed as one of the most compelling growth names in his coverage that investors should own. The analyst reiterates an Overweight rating and $480 price target on the shares.

  • 27

    Nov

ABMD Abiomed
$405.08

-8.51 (-2.06%)

11/05/18
PIPR
11/05/18
NO CHANGE
Target $480
PIPR
Overweight
Abiomed feasibility study on Impella to be positive, says Piper Jaffray
The next catalyst for Abiomed following earnings last week is the release of the STEMI feasibility study on Impella in severe heart attack patients at the American Heart Association meeting in Chicago on November 11, Piper Jaffray analyst Matt O'Brien tells investors in a research note. The analyst anticipates the results of the feasibility study will prove positive and his analysis yields 200,000 U.S. STEMI patients and ~$5B market opportunity. A positive update on November 11 will likely push Abiomed shares even higher, O'Brien writes. He reiterates an Overweight rating on the shares with a $480 price target.
11/05/18
11/05/18
NO CHANGE
Target $400

Buy
Abiomed data could help double addressable market, says Jefferies
Abiomed will report data from its ST segment elevation myocardial infarction Door to Unloading study on November 11, Jefferies analyst Raj Denhoy tells investors in a research note. The analyst says that while only designed as a feasibility study with 50 patients, the rationale for the study and results from previous studies suggest it could show more than just equivalence. Any positive result would add support to the idea that Abiomed is well on its way to opening up a market of 200,000-300,000 patients per year worth $4B-$6B in the U.S. alone, says Denhoy. This would essentially double the addressable market for Impella, the analyst adds. He keeps a Buy rating on Abiomed with a $400 price target.
11/07/18
MSCO
11/07/18
UPGRADE
MSCO
Overweight
Abiomed upgraded to Overweight from Equal Weight at Morgan Stanley
11/07/18
11/07/18
UPGRADE
Target $496

Overweight
Abiomed upgraded to Overweight ahead of DTU trial readout at Morgan Stanley
As previously reported, Morgan Stanley analyst David Lewis upgraded Abiomed to Overweight from Equal Weight, stating that based on his review of pre-clinical and clinical data and physician conversations he has conviction in a positive readout from the Door to Unloading, or STEMI-DTU, trial next week. Data is to be presented at the American Heart Association Scientific Sessions on Sunday, November 11, the analyst noted. Abiomed's DTU trial challenges the current paradigm and success could result in a shift from the current standard of care, driving an inflection in valuation, Lewis tells investors. The ST-elevated myocardial infarctions, or STEMI, opportunity would expand Abiomed's current addressable market by about 70%, Lewis added. He raised his price target on Abiomed shares to $496 from $396.

TODAY'S FREE FLY STORIES

03:00
01/17/19
01/17
03:00
01/17/19
03:00
General news
FX Update: An abatement in risk appetite has impacted currencies »

FX Update: An abatement…

01:50
01/17/19
01/17
01:50
01/17/19
01:50
General news
Asian Market Wrap: »

Asian Market Wrap:…

RVNC

Revance

$18.11

-2.11 (-10.44%)

21:05
01/16/19
01/16
21:05
01/16/19
21:05
Syndicate
Revance 5.9M share Secondary priced at $17.00 »

Goldman Sachs, Cowen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

MRTX

Mirati Therapeutics

$62.51

-2.33 (-3.59%)

20:49
01/16/19
01/16
20:49
01/16/19
20:49
Syndicate
Mirati Therapeutics 1.6M share Spot Secondary priced at $62.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

BREW

Craft Brew

$15.50

0.19 (1.24%)

20:45
01/16/19
01/16
20:45
01/16/19
20:45
Initiation
Craft Brew initiated at Maxim »

Craft Brew initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROX

Castle Brands

$0.91

0.0122 (1.36%)

20:41
01/16/19
01/16
20:41
01/16/19
20:41
Initiation
Castle Brands initiated at Maxim »

Castle Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRT

PermRock Royalty Trust

$9.61

-0.39 (-3.90%)

20:39
01/16/19
01/16
20:39
01/16/19
20:39
Downgrade
PermRock Royalty Trust rating change at Stifel »

PermRock Royalty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GBCI

Glacier Bancorp

$42.87

1.36 (3.28%)

20:38
01/16/19
01/16
20:38
01/16/19
20:38
Hot Stocks
Glacier Bancorp acquires FNB Bancorp »

Glacier Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 12

    Mar

ERJ

Embraer

$22.81

-0.59 (-2.52%)

20:34
01/16/19
01/16
20:34
01/16/19
20:34
Downgrade
Embraer rating change at Morgan Stanley »

Embraer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AICAF

Air China

$0.00

(0.00%)

20:32
01/16/19
01/16
20:32
01/16/19
20:32
Upgrade
Air China rating change at HSBC »

Air China upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEA

China Eastern Airlines

$28.64

-0.09 (-0.31%)

20:26
01/16/19
01/16
20:26
01/16/19
20:26
Upgrade
China Eastern Airlines rating change at HSBC »

China Eastern Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$44.48

1.59 (3.71%)

, BBT

BB&T

$47.55

1.2 (2.59%)

20:25
01/16/19
01/16
20:25
01/16/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MS

Morgan Stanley

$44.48

1.59 (3.71%)

BBT

BB&T

$47.55

1.2 (2.59%)

PPG

PPG

$102.58

1.58 (1.56%)

MTB

M&T Bank

$154.45

3.04 (2.01%)

KEY

KeyCorp

$16.75

0.44 (2.70%)

FAST

Fastenal

$54.11

-0.47 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 17

    Jan

  • 11

    Feb

  • 23

    May

  • 18

    Oct

FDC

First Data

$21.27

3.72 (21.20%)

20:07
01/16/19
01/16
20:07
01/16/19
20:07
Downgrade
First Data rating change at Goldman Sachs »

First Data downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

VEON

Veon

$2.56

-0.03 (-1.16%)

19:44
01/16/19
01/16
19:44
01/16/19
19:44
Downgrade
Veon rating change at VTB Capital »

Veon downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,682.84

7.84 (0.47%)

19:22
01/16/19
01/16
19:22
01/16/19
19:22
Hot Stocks
Amazon announces AWS Backup service »

Amazon Web Service, an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 28

    Jan

  • 20

    Feb

  • 03

    Mar

GS

Goldman Sachs

$197.03

17.12 (9.52%)

19:09
01/16/19
01/16
19:09
01/16/19
19:09
Periodicals
WSJ's "Heard on the Street" column says to look past Goldman Sachs Q4 glitter »

The Wall Street…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

TSLA

Tesla

$346.03

1.78 (0.52%)

18:57
01/16/19
01/16
18:57
01/16/19
18:57
Periodicals
CA makes up large portion of Tesla Model 3 registrations in 2018, Bloomberg says »

The state of California…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

CARS

Cars.com

$23.14

-0.26 (-1.11%)

, MNKD

MannKind

$1.32

-0.06 (-4.35%)

18:46
01/16/19
01/16
18:46
01/16/19
18:46
Hot Stocks
Fly Intel: After Hours Movers »

HIGHER: Cars.com (CARS)…

CARS

Cars.com

$23.14

-0.26 (-1.11%)

MNKD

MannKind

$1.32

-0.06 (-4.35%)

FOLD

Amicus

$12.18

0.19 (1.58%)

FUL

H.B. Fuller

$43.35

0.09 (0.21%)

PLXS

Plexus

$54.88

1.195 (2.23%)

CSX

CSX

$65.36

0.27 (0.41%)

KMI

Kinder Morgan

$17.46

0.15 (0.87%)

AA

Alcoa

$29.02

0.13 (0.45%)

ACB

Aurora Cannabis

$7.33

0.35 (5.01%)

MRTX

Mirati Therapeutics

$62.51

-2.33 (-3.59%)

AAPL

Apple

$154.88

1.84 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

  • 16

    Jan

  • 17

    Jan

  • 17

    Jan

  • 29

    Jan

  • 29

    Jan

  • 10

    Feb

  • 11

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    May

  • 17

    Jan

BAC

Bank of America

$28.44

1.89 (7.12%)

18:46
01/16/19
01/16
18:46
01/16/19
18:46
Periodicals
BofA's global investment banking head to leave bank, FT reports »

Bank of America's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 12

    Feb

  • 03

    Mar

NEWR

New Relic

$90.47

1.38 (1.55%)

18:44
01/16/19
01/16
18:44
01/16/19
18:44
Hot Stocks
New Relic CEO: 'We are an app-centric company' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 25

    Jan

  • 06

    Feb

  • 25

    Feb

  • 14

    Mar

TME

Tencent Music

$12.99

0.57 (4.59%)

18:33
01/16/19
01/16
18:33
01/16/19
18:33
Initiation
Tencent Music initiated at JPMorgan »

Tencent Music initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASCMA

Ascent Capital

$0.40

-0.0499 (-11.09%)

18:27
01/16/19
01/16
18:27
01/16/19
18:27
Hot Stocks
Ascent Capital announces strategic review »

Ascent Capital Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMS

CMS Energy

$50.56

0.34 (0.68%)

18:19
01/16/19
01/16
18:19
01/16/19
18:19
Initiation
CMS Energy initiated at Goldman Sachs »

CMS Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

DTE

DTE Energy

$111.73

0.48 (0.43%)

18:15
01/16/19
01/16
18:15
01/16/19
18:15
Initiation
DTE Energy initiated at Goldman Sachs »

DTE Energy initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

18:15
01/16/19
01/16
18:15
01/16/19
18:15
General news
Breaking General news story  »

Minneapolis Federal…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.